Lanean...

Current Developments in the Use of Biomarkers for Juvenile Idiopathic Arthritis

Use of biomarkers in clinical practice has proved extremely valuable and is a rapidly expanding field. However, despite the huge potential of biomarkers, for juvenile idiopathic arthritis (JIA) there are currently no validated paediatric biomarkers available to help with setting up a more tailored a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Duurland, Chantal L., Wedderburn, Lucy R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2014
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930839/
https://ncbi.nlm.nih.gov/pubmed/24445961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-013-0406-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!